Colchicine Dosing for Acute and Chronic Gout

Acute Gout Treatment

For acute gout flares, administer colchicine 1.2 mg at the first sign of symptoms, followed by 0.6 mg one hour later (total 1.8 mg over 1 hour), then continue with 0.6 mg once or twice daily starting 12 hours after the initial doses until the flare resolves. 1, 2

Critical Timing Consideration

Colchicine must be initiated within 36 hours of symptom onset to be effective—delaying treatment beyond this window significantly reduces efficacy and is not recommended. 1, 2

Dosing Adjustments for Renal Impairment in Acute Gout

Mild to moderate renal impairment (CrCl 30-80 mL/min):

No dose adjustment required for the acute treatment regimen (1.2 mg followed by 0.6 mg one hour later) 3
Monitor closely for adverse effects 3

Severe renal impairment (CrCl <30 mL/min):

Use the standard acute dose (1.2 mg + 0.6 mg), but do not repeat the treatment course for at least 2 weeks 3
Consider alternative therapy if repeated courses are needed 3

Dialysis patients:

Administer only a single 0.6 mg dose 2, 3
Do not repeat treatment for at least 2 weeks 2, 3

Prophylaxis Dosing for Chronic Gout

The standard prophylactic dose is 0.6 mg once or twice daily, initiated with or just prior to starting urate-lowering therapy. 1, 2

Duration of Prophylaxis

Continue for at least 6 months 1
Or 3 months after achieving target serum urate if no tophi are present on physical examination 1
Or 6 months after achieving target serum urate if tophi are detected 1

Dosing Adjustments for Renal Impairment in Prophylaxis

Mild to moderate renal impairment (CrCl 30-80 mL/min):

No dose adjustment required, but monitor closely for adverse effects 3

Severe renal impairment (CrCl <30 mL/min):

Start with 0.3 mg once daily 3
Any dose increase requires close monitoring for adverse effects 3

Dialysis patients:

Start with 0.3 mg twice weekly 3
Monitor closely; dosing can be increased cautiously with adequate monitoring 3

Critical Drug Interactions

Colchicine has life-threatening interactions with CYP3A4 and P-glycoprotein inhibitors that require mandatory dose reductions. 1, 3

Major Interacting Drugs Requiring Dose Reduction:

Clarithromycin, erythromycin 1, 3
Cyclosporine 1
All protease inhibitors (ritonavir, atazanavir, indinavir, lopinavir, nelfinavir, saquinavir, tipranavir, fosamprenavir) 3

Dose Adjustments with Strong CYP3A4/P-gp Inhibitors:

For acute gout treatment:

Reduce to 0.6 mg × 1 dose, followed by 0.3 mg one hour later 3
Do not repeat for at least 3 days 3

For prophylaxis:

If taking 0.6 mg twice daily: reduce to 0.3 mg once daily 3
If taking 0.6 mg once daily: reduce to 0.3 mg every other day 3

Critical caveat: Patients with renal or hepatic impairment should not receive colchicine when taking these interacting medications. 3

Treatment of acute gout flares is not recommended in patients already receiving prophylactic colchicine plus CYP3A4 inhibitors. 3

Hepatic Impairment Considerations

Mild to moderate hepatic impairment:

No dose adjustment required for prophylaxis, but monitor closely 3

Severe hepatic impairment:

Consider dose reduction for prophylaxis 3

Common Pitfalls to Avoid

Do not use high-dose colchicine regimens (the outdated "hourly dosing until diarrhea" approach)—the low-dose regimen (1.8 mg total over 1 hour) is equally effective with significantly fewer side effects. 4, 1
Do not initiate colchicine for acute gout if symptoms began more than 36 hours ago—effectiveness is markedly reduced. 1, 2
Do not overlook drug interactions—failure to adjust doses with CYP3A4 inhibitors can result in fatal colchicine toxicity. 3, 5
Do not treat acute flares in patients on prophylactic colchicine who are also taking CYP3A4 inhibitors—this combination significantly increases toxicity risk. 3
Do not use standard dosing in dialysis patients—a single 0.6 mg dose with no repeat for 2 weeks is the maximum safe approach. 2, 3

Alternative Therapies When Colchicine is Contraindicated

When colchicine cannot be used due to renal impairment, drug interactions, or other contraindications, the American College of Rheumatology recommends: 4, 2

NSAIDs at full approved doses until complete resolution (if no contraindications) 2
Oral corticosteroids: prednisone 0.5 mg/kg/day for 5-10 days, then stopped or tapered over 7-10 days 2
Intra-articular corticosteroid injections for monoarticular or oligoarticular involvement (dose varies by joint size) 2

What is the recommended dosing for colchicine (Colchicine) in patients with acute and chronic gout, especially those with Impaired renal function?

Help us tailor your experience